Urbanija Jasna, Tomsic Nejc, Lokar Marusa, Ambrozic Ales, Cucnik Sasa, Rozman Blaz, Kanduser Masa, Iglic Ales, Kralj-Iglic Veronika
Laboratory of Clinical Biophysics, Faculty of Medicine, University of Ljubljana, Lipiceva 2, Ljubljana, Slovenia.
Chem Phys Lipids. 2007 Nov;150(1):49-57. doi: 10.1016/j.chemphyslip.2007.06.216. Epub 2007 Jun 23.
Interactions between phospholipid membranes (made of palmitoyloleoylphosphatidylcholine, cardiolipin and cholesterol) after addition of beta2 glycoprotein I (beta2GPI) or anti-beta2GPI antibodies or a mixture of both were studied by observing giant phospholipid vesicles under the phase contrast microscope. Both, negatively charged and neutral vesicles coalesced into complexes and adhered to the bottom of the observation chamber in the presence of beta2GPI in solution. Anti-beta2GPIs alone or previously mixed with beta2GPI caused coalescence of charged but not neutral vesicles, i.e. for neutral membranes the effect of beta2GPI was abolished by the presence of anti-beta2GPIs. Since the presence of the above adhesion mediators can prevent fragmentation of the membrane we propose a (new) possible anticoagulant mechanism for some serum proteins by preventing the release of prothrombogenic microexovesicles into circulation.
通过在相差显微镜下观察巨型磷脂囊泡,研究了添加β2糖蛋白I(β2GPI)或抗β2GPI抗体或两者混合物后磷脂膜(由棕榈酰油酰磷脂酰胆碱、心磷脂和胆固醇制成)之间的相互作用。在溶液中存在β2GPI的情况下,带负电荷的囊泡和中性囊泡都会聚集成复合物并粘附在观察室底部。单独的抗β2GPI或预先与β2GPI混合的抗β2GPI会导致带电荷的囊泡聚集,但不会导致中性囊泡聚集,即对于中性膜,抗β2GPI的存在会消除β2GPI的作用。由于上述粘附介质的存在可以防止膜的破碎,我们提出了一种(新的)可能的抗凝机制,即某些血清蛋白通过防止促血栓形成的微小外囊泡释放到循环中发挥抗凝作用。